- Home
- SHMD vs CRVO Comparison
SHMD vs CRVO Comparison
Compare SHMD & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHMD
- CRVO
- Stock Information
- Founded
- SHMD 1864
- CRVO 2001
- Country
- SHMD Germany
- CRVO United States
- Employees
- SHMD N/A
- CRVO N/A
- Industry
- SHMD
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- SHMD
- CRVO Health Care
- Exchange
- SHMD Nasdaq
- CRVO Nasdaq
- Market Cap
- SHMD 144.3M
- CRVO 98.3M
- IPO Year
- SHMD N/A
- CRVO N/A
- Fundamental
- Price
- SHMD $2.58
- CRVO $2.13
- Analyst Decision
- SHMD
- CRVO Buy
- Analyst Count
- SHMD 0
- CRVO 8
- Target Price
- SHMD N/A
- CRVO $38.75
- AVG Volume (30 Days)
- SHMD 51.8K
- CRVO 476.7K
- Earning Date
- SHMD 02-25-2025
- CRVO 11-12-2024
- Dividend Yield
- SHMD N/A
- CRVO N/A
- EPS Growth
- SHMD 1309.32
- CRVO N/A
- EPS
- SHMD 1.07
- CRVO N/A
- Revenue
- SHMD $99,752,404.00
- CRVO $10,066,550.00
- Revenue This Year
- SHMD N/A
- CRVO $34.17
- Revenue Next Year
- SHMD N/A
- CRVO N/A
- P/E Ratio
- SHMD $2.30
- CRVO N/A
- Revenue Growth
- SHMD N/A
- CRVO 116.29
- 52 Week Low
- SHMD $1.98
- CRVO $1.80
- 52 Week High
- SHMD $6.13
- CRVO $26.38
- Technical
- Relative Strength Index (RSI)
- SHMD N/A
- CRVO 28.45
- Support Level
- SHMD N/A
- CRVO $1.99
- Resistance Level
- SHMD N/A
- CRVO $2.43
- Average True Range (ATR)
- SHMD 0.00
- CRVO 0.17
- MACD
- SHMD 0.00
- CRVO 0.31
- Stochastic Oscillator
- SHMD 0.00
- CRVO 26.92
About SHMD SCHMID Group N.V. Class A Ordinary Shares
Schmid Group NV is a global supplier of equipment, software and services for various industries such as printed circuit board (PCB), substrate manufacturing, photovoltaics, and glass and energy storage with a focus on the highest end of this market in terms of technology and performance. It focuses on a modular product portfolio of machinery to use in the manufacturing of high-end PCB equipment and semiconductor packaging devices which includes common flexible circuit fabrication techniques such as subtractive, semi-additive processes (SAP) and modified semi-additive processes (mSAP).
About CRVO CervoMed Inc.
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.